Literature DB >> 16247635

[Innovative concepts in early cancer detection and staging of localized prostate cancer].

L Rinnab1, R Küfer, R E Hautmann, B G Volkmer, M Straub, N M Blumstein, H W Gottfried.   

Abstract

Prostate cancer is the most common malignancy in males. Men aged 50 years and older are recommended to undergo an annual digital rectal examination (DRE) and determination of prostate-specific antigen (PSA) in serum for early detection. Fortunately, disease-specific mortality continues to decline as a result of advances in screening, staging, and patient awareness. However, about 30% of men with a clinically organ-confined disease show evidence of extracapsular extension or seminal vesicle invasion on pathological analysis. Consequently, there is a need for more accurate diagnostic tools for planning tailored treatment. A variety of modern imaging techniques has been implemented in an attempt to obtain more precise staging, thereby allowing for more detailed counseling, and instituting optimum therapy. This review highlights developments in prostate cancer imaging that may improve staging and treatment planning for prostate cancer patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247635     DOI: 10.1007/s00120-005-0931-4

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  73 in total

1.  Prostate cancer: contrast-enhanced us for detection.

Authors:  E J Halpern; M Rosenberg; L G Gomella
Journal:  Radiology       Date:  2001-04       Impact factor: 11.105

2.  Induction of angiogenesis during the transition from hyperplasia to neoplasia.

Authors:  J Folkman; K Watson; D Ingber; D Hanahan
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

3.  Staging of prostate cancer using 3-dimensional transrectal ultrasound images: a pilot study.

Authors:  S Garg; B Fortling; D Chadwick; M C Robinson; F C Hamdy
Journal:  J Urol       Date:  1999-10       Impact factor: 7.450

4.  Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.

Authors:  C Hofer; C Laubenbacher; T Block; J Breul; R Hartung; M Schwaiger
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

5.  Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.

Authors:  T R DeGrado; R E Coleman; S Wang; S W Baldwin; M D Orr; C N Robertson; T J Polascik; D T Price
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

6.  [Improvement of transrectal ultrasound. Artificial neural network analysis (ANNA) in detection and staging of prostatic carcinoma].

Authors:  T Loch; I Leuschner; C Genberg; K Weichert-Jacobsen; F Küppers; M Retz; J Lehmann; E Yfantis; M Evans; V Tsarev; M Stöckle
Journal:  Urologe A       Date:  2000-07       Impact factor: 0.639

Review 7.  [Positron emission tomography (PET) for diagnosis and monitoring of treatment for urological tumors].

Authors:  S Machtens; A R Boerner; M Hofmann; W H Knapp; U Jonas
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

8.  [Computerized supported transrectal ultrasound (C-TRUS) in the diagnosis of prostate cancer].

Authors:  T Loch
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

9.  [The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].

Authors:  H Hautzel; V Müller-Mattheis; H Herzog; W Roden; H H Coenen; R Ackermann; H W Müller-Gärtner; B J Krause
Journal:  Urologe A       Date:  2002-11       Impact factor: 0.639

10.  Diagnosis of prostatic carcinoma: the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.

Authors:  W J Ellis; M P Chetner; S D Preston; M K Brawer
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.